The renin–angiotensin system and diabetes: An update

References

• AbdallaSLotherHQuittererU2000AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestrationNature40794810993080
   PubMed Web of Science ®Google Scholar
• AgarwalR2003Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockadeAm J Physiol Renal Physiol284F863912505865
   PubMed Web of Science ®Google Scholar
• AlbistonALMcDowallSGMatsacosD2001Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated ami nopeptidaseJ Biol Chem27648623611707427
   PubMed Web of Science ®Google Scholar
• AlbistonALPeckGRYeatmanHR2007Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?Pharmacol Ther1164172717900701
   PubMed Web of Science ®Google Scholar
• AlbistonALPedersonESBurnsP2004Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigmsBehav Brain Res1542394315302130
   PubMed Web of Science ®Google Scholar
• AndersonSJungFFIngelfingerJR1993Renal renin-angiotensin system in diabetes: functional immunohistochemical and molecular biological correlationsAm J Physiol265F4774868238377
   PubMedGoogle Scholar
• BakerKMCherninMISchreiberT2004Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophyRegul Pept12051315177915
   PubMed Web of Science ®Google Scholar
• BedecsKElbazNSutremM1997Angiotensin II type 2 receptors mediate inhibition of mitogen activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphataseBiochem J325449549230127
   PubMed Web of Science ®Google Scholar
• BenterIFYousifMHDhaunsiGS2008Angiotensin (1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive ratsAm J Nephrol28253317890855
   PubMed Web of Science ®Google Scholar
• BjorkS1990The renin-angiotensin system in diabetes mellitus: a physiological and therapeutic studyScand J Urol Nephrol126150
   Google Scholar
• BloemLJManatungaAKTewksburyDA1995The serum angio-tensinogen concentration and variants of the angiotensinogen gene in white and black childrenJ Clin Invest95948537883995
   PubMed Web of Science ®Google Scholar
• BojestigMNystromFHArnqvistHJ2000The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetesJ Renin Angiotensin Aldosterone Syst1353611967822
   PubMedGoogle Scholar
• BraszkoJJWalesiukAWielgatP2006Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IVJ Renin Angiotensin Aldosterone Syst71687417094054
   PubMed Web of Science ®Google Scholar
• Braun-MenendezEFascioloJCLeloirLF1940The substance causing renal hypertensionJ Physiol (Lond)982839816995204
   PubMedGoogle Scholar
• BrennerBMCooperMEde ZeeuwD2001Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Eng J Med3458619
   PubMed Web of Science ®Google Scholar
• BrewsterUCPerazellaMA2004The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseAm J Med1162637214969655
   PubMed Web of Science ®Google Scholar
• BrosnihanKBLiPFerrarioCM1996Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxideHypertension2752388613197
   PubMed Web of Science ®Google Scholar
• BrosnihanKBNevesLAAntonL2004Enhanced expression of Ang (1–7) during pregnancyBraz J Med Biol Res3712556215273828
   PubMed Web of Science ®Google Scholar
• CaglayanEBlaschkeFTakataY2005Metabolic syndrome interdependence of the cardiovascular and metabolic pathwaysCurr Opin Pharmacol51354215780821
   PubMed Web of Science ®Google Scholar
• Campagnole-SantosMJDizDISantosRAS1989Cardiovascular effects of angiotensin-(1–7) injected into the dorsal medulla of ratsAm J Physiol257H32492750946
   PubMed Web of Science ®Google Scholar
• CampbellDJ2003The renin angiotensin and kallikrein kinin systemsInt J Biochem Cell Biol357849112676165
   PubMed Web of Science ®Google Scholar
• CardilloCPanzaJA1998Impaired endotelial regulation of vascular tone in patients with systemic arterial hypertensionVasc Med3138449796077
   PubMedGoogle Scholar
• CareyRMSiragyHM2003aNewly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulationEndocr Rev2432617112788798
   PubMed Web of Science ®Google Scholar
• CareyRMSiragyHM2003bThe intrarenal renin-angiotensin system and diabetic nephropathyTrends Endocrinol Metab1462748112890592
   PubMed Web of Science ®Google Scholar
• CesariMRossiGPPessinaAC2002Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseasesJ Hypertens20793912011628
   PubMedGoogle Scholar
• ChappellMCModrallJGDizDI2004Novel aspects of the renal Renin-Angiotensin System: Angiotensin-(1–7), ACE2 and blood pressure regulationContrib Nephrol143778915248357
   PubMed Web of Science ®Google Scholar
• ChappellMC2007Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1–7)-Mas receptor axis: More than regulation of blood pressure?Hypertension50596917785634
   PubMed Web of Science ®Google Scholar
• ChaySRFernandoRPeckG2004The angiotensin IV/AT4 receptorCell Mol Life Sci6127283715549174
   PubMed Web of Science ®Google Scholar
• ChenSPatelJMBlockER2000Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium releaseAm J Physiol279L84956
   Google Scholar
• CipolloneFFaziaMLMezzetiA2006Role of angiotensin II receptor blockers in atherosclerotic plaque stabilityExpert Opin Pharmacother72778516448322
   PubMed Web of Science ®Google Scholar
• ClarkMAGuillaumeGPierre-LouisHC2008Angiotensin II induces proliferation of cultured rat astrocytes through c-Jun N-terminal kinaseBrain Res Bull75101618158102
   PubMed Web of Science ®Google Scholar
• CooperMETikellisCThomasMC2006Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin systemJ Hypertens Suppl24S576316601575
   PubMedGoogle Scholar
• DahlofBDevereuxRBKjeldsenSE2002Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomized trial against atenololLancet359995100311937178
   PubMed Web of Science ®Google Scholar
• DanserAH2003Local renin-angiotensin systems: the unanswered questionsInt J Biochem Cell Biol357596812676161
   PubMed Web of Science ®Google Scholar
• De GasparoMCattKJInagamiT2000International union of pharmacology. XXIII. The angiotensin II receptorsPharmacol Rev524157210977869
   PubMed Web of Science ®Google Scholar
• De MattiaGFerriCLaurentiO1996Circulating cathecolamines and metabolic effects of captopril in NIDDM patientsDiabetes Care19226308742566
   PubMed Web of Science ®Google Scholar
• DeckertT1994Nephropathy and coronary death: the fatal twins in diabetes mellitusNephrol Dial Transplant91069717800202
   PubMed Web of Science ®Google Scholar
• DeddishPAMarcicBJackmanHL1998N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1–7) and keto-ACEHypertension31912179535414
   PubMed Web of Science ®Google Scholar
• DonoghueMHsiehFBaronasE2000A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9Circ Res87E1910969042
   PubMed Web of Science ®Google Scholar
• DoriaAOnumaTWarramJH1997Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDMDiabetologia401293999389421
   PubMed Web of Science ®Google Scholar
• FeiDTCoghlanJPFernleyRT1980Peripheral production of angiotensin II and III in sheepCirc Res46I13577379257
   PubMed Web of Science ®Google Scholar
• FerrarioCAbdelhamedAIMooreM2004Angiotensin II antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartanCurr Med Res Opin202799315025837
   PubMed Web of Science ®Google Scholar
• FerrarioCMJessupJGallagherPE2005Effects of renin-angiotensin system blockade on renal angiotensin-(1–7) forming enzymes and receptorsKidney Int6821899616221218
   PubMed Web of Science ®Google Scholar
• FerrarioCMMartellNYunisC1998Characterization of angiotensin-(1–7) in the urine of normal and essential hypertensive subjectsAm J Hypertens11137469524041
   PubMed Web of Science ®Google Scholar
• FolliFSaadMJVellosoL1999Crosstalk between insulin and angiotensin II signalling systemsExp Clin Endocrinol Diabetes107133910320054
   PubMed Web of Science ®Google Scholar
• Fraga-SilvaRAPinheiroSVGonçalvesAC2008The Antithrombotic Effect of Angiotensin-(1–7) Involves Mas-Mediated NO Release from PlateletsMol Med14283518026570
   PubMed Web of Science ®Google Scholar
• FreemanEJChisolmGMFerrarioCM1996Angiotensin (1–7) inhibits vascular smooth muscle cell growthHypertension2810488675248
   PubMed Web of Science ®Google Scholar
• FrossardMJoukhadarCSteffenG2000Paracrine effects of angiotensin-converting-enzyme-and angiotensin-II-receptor-inhibition on transcapillary glucose transport in humansLife Sci6614754
   Web of Science ®Google Scholar
• FuruhashiMUraNTakizawaH2004Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivityJ Hypertens2219778215361770
   PubMed Web of Science ®Google Scholar
• GallagherPETallantEA2004Inhibition of human lung cancer cell growth by angiotensin-(1–7)Carcinogenesis2520455215284177
   PubMed Web of Science ®Google Scholar
• GantenDMarquez-JulioAGrangerP1971Renin in dog brainAm J Physiol221173374330904
   PubMed Web of Science ®Google Scholar
• GiacchettiGSechiLARilliS2005The renin-angiotensin-aldosterone system, glucose metabolism and diabetesTrends Endocrinol Metab16120615808810
   PubMed Web of Science ®Google Scholar
• GlossmannHBaukalACattKJ1974Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotidesJ Biol Chem24966464358562
   PubMed Web of Science ®Google Scholar
• GrossCMPerrotAGeierC2007Recurrent in-stent restenosis is not associated with the angiotensin converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphismJ Invasive Cardiol19261417541127
   PubMedGoogle Scholar
• GumprechtJZychmaMJGrzeszczakW2000End-stage renal disease study group. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failureKidney Int585131910916074
   PubMed Web of Science ®Google Scholar
• HallJEBrandsMWHenegarJR1999Angiotensin II and long term arterial pressure regulation: the overriding dominance of the kidneyJ Am Soc Nephrol10S2586510201880
   PubMed Web of Science ®Google Scholar
• HallJE1991The renin-angiotensin system: renal actions and blood pressure regulationCompr Ther178171879129
   PubMedGoogle Scholar
• HandaRK1999Angiotensin-(1–7) can interact with the rat proximal tubule AT(4) receptor systemAm J Physiol277F75F8310409300
   PubMedGoogle Scholar
• [HOPE] Heart Outcomes Prevention Evaluation Study Investigators2000Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudyLancet355253910675071
   PubMed Web of Science ®Google Scholar
• HerathCBWarnerFJLubelJS2007Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and Angiotensin-(1–7) levels in experimental billiary fibrosisJ Hepatol473879517532087
   PubMed Web of Science ®Google Scholar
• HsuehWAQuiñonesMJ2003Role of endothelial dysfunction in insulin resistanceAm J Card9210J17J
   PubMed Web of Science ®Google Scholar
• HunyadyLCattKJ2006Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin IIMol Endocrinol209537016141358
   PubMed Web of Science ®Google Scholar
• IchikawaIHarrisRC1991Angiotensin actions in the kidney. Renewed insight into the old hormoneKidney Int40583961745006
   PubMed Web of Science ®Google Scholar
• JackmanHLMassadMGSekosanM2002Angiotensin 1–9 and 1–7 release in human heart: role of cathepsin AHypertension399768112019279
   PubMed Web of Science ®Google Scholar
• JacquesDAbdel MalakNASaderS2003Angiotensin II and its receptors in human endocardial endothelial cells : role in modulating intracellular calciumCan J Physiol Pharmacol812596612733824
   PubMed Web of Science ®Google Scholar
• JamersonKANesbittSDAmerenaJV1996Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effectsHypertension2785488613260
   PubMed Web of Science ®Google Scholar
• Jandeleit-DahmKATikellisCReidCM2005Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesJ Hypertens234637315716683
   PubMed Web of Science ®Google Scholar
• JankowskiVVanholderRvan der GietM2007Mass-spectrometric identification of a novel angiotensin peptide in human plasmaArterioscler Thromb Vasc Biol2729730217138938
   PubMed Web of Science ®Google Scholar
• JanssonPA2007Endothelial dysfunction in insulin resistance and type 2 diabetesJ Intern Med2621738317645585
   PubMed Web of Science ®Google Scholar
• KagamiSBorderWAMillerDE1994Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in the rat glomerular mesangial cellsJ Clin Invest93243178200978
   PubMed Web of Science ®Google Scholar
• KalantariniaKOkusaMD2006The renin-angiotensin system and its blockade in diabetic renal and cardiovascular diseaseCurr Diab Rep681616522275
   PubMedGoogle Scholar
• KambayashiYBardhanSTakahashiK1993Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibitionJ Biol Chem2682454368227011
   PubMed Web of Science ®Google Scholar
• KangD-HKanellisJHugoC2002Role of the microvascular endothelium in progressive renal diseaseJ Am Soc Nephrol138061611856789
   PubMed Web of Science ®Google Scholar
• Karwowska-PoleckaWKulakowskaAWisniewskiK1997Losartan influences behavioral effects of angiotensin II (3–7) in ratsPharmacol Res36275839425616
   PubMed Web of Science ®Google Scholar
• KohlstedtKBrandesRPMuller-EsterlW2004Angiotensin-converting enzyme is involved in outsidein signaling in endothelial cellsCirc Res9460714615289
   PubMed Web of Science ®Google Scholar
• KostenisEMilliganGChristopoulosA2005G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptorCirculation11118061315809376
   PubMed Web of Science ®Google Scholar
• KucharewiczIPawlakRMatysT2002Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1–7)Hypertension40774912411476
   PubMed Web of Science ®Google Scholar
• LauTCarlssonPOLeungPS2004Evidence for a local angiotensin-generating system and dose dependent inhibition of glucose stimulated insulin release by angiotensin II in isolated pancreatic isletsDiabetologia47240814722647
   PubMed Web of Science ®Google Scholar
• LavoieJLSigmundCD2003Minireview: overview of the renin-angiotensin system-an endocrine and paracrine systemEndocrinology14421798312746271
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkWRfor The Collaborative Study Group2001Renoprotective effect of the angiotensin receptor antagonist irbersartan in patients with nephropathy due to type 2 diabetesN Engl J Med3458516011565517
   PubMed Web of Science ®Google Scholar
• LiMLiuKMichalicekJ2004Involvement of chymase-mediated angiotensin II generation in blood pressure regulationJ Clin Invest1141122015232618
   PubMed Web of Science ®Google Scholar
• LiXCCampbellDJOhishiM2006AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in ratsAm J Physiol290F102433
   PubMed Web of Science ®Google Scholar
• LiebWGrafJGotzA2006Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudyJ Mol Med84889616283142
   PubMed Web of Science ®Google Scholar
• LindholmLHIbsenHDahlofB2002Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE). A randomized trial against atenololLancet35910041011937179
   PubMed Web of Science ®Google Scholar
• LupiRDel GuerraSBuglianiM2006The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic isletsEur J Endocrinol1543556116452552
   PubMed Web of Science ®Google Scholar
• LuqueMMartinPMartellN1996Effects of captopril related to increased levels of prostacyclin and angiotensin-(1–7) in essential hypertensionJ Hypertens147998058793704
   PubMed Web of Science ®Google Scholar
• MaiaLGRamosMCFernandesL2004Angiotensin – (1–7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in ratsJ Cardiovasc Pharmacol436859115071356
   PubMed Web of Science ®Google Scholar
• MatayoshiTKamideKTakiuchiS2007Relationship between insulin resistance and the renin-angiotensin system: analysis for patients with essential and renovascular hypertensionClin Exp Hypertens294798718041161
   PubMed Web of Science ®Google Scholar
• MeigsJB2003The metabolic syndromeBr Med J32761212855493
   PubMed Web of Science ®Google Scholar
• MerrilDCKarolyMChenK2002Angiotensin–(1–7) in normal and pre-elamptic pregnancyEndocrine182394512450315
   PubMed Web of Science ®Google Scholar
• MervaalaEMMullerDNParkJK1999Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertensionHypertension33389959931135
   PubMed Web of Science ®Google Scholar
• MiyazakiMTakaiS2006Tissue angiotensin II generating system by angiotensin-converting enzyme and chymaseJ Pharmacol Sci100391716799256
   PubMed Web of Science ®Google Scholar
• MogensenCE1984Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetesN Eng J Med31035660
   PubMed Web of Science ®Google Scholar
• MogielnickiAKramkowskiKChabielskaE2003Angiotensin 1–9 influences hemodynamics and hemostatics parameters in ratsPol J Pharmacol555034
   Google Scholar
• MukaiYShimokawaHHigashiM2002Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging ratsArterioscler Thromb Vasc Biol2214455012231564
   PubMed Web of Science ®Google Scholar
• MukoyamaMNakajimaMHoriuchiM1993Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptorsJ Biol Chem26824539428227010
   PubMed Web of Science ®Google Scholar
• MullerMFaschingPSchmidR1997Inhibition of paracrine angiotensin-converting enzyme in vivo: effects on interstitial glucose and lactate concentrations in human skeletal muscleEur J Clin Invest27825309373760
   PubMed Web of Science ®Google Scholar
• MurphyTJAlexanderRWGriendlingKK1991Isolation of a cDNA encoding the vascular type-1 angiotensin II receptorNature35123362041570
   PubMed Web of Science ®Google Scholar
• NaberCKSiffertW2004Genetics of human arterial hypertensionMinerva Med953475615467511
   PubMedGoogle Scholar
• NagataSKatoJSasakiK2006Isolation and identification of pro-angiotensin-12, a possible component of the renin-angiotensin systemBiochem Biophys Res Comm35010263117045572
   PubMed Web of Science ®Google Scholar
• NakagawaTSegalMCrokerB2007A breakthrough in diabetic nephropathy: the role of endothelial dysfunctionNephrol Dial Transplant222775717595179
   PubMed Web of Science ®Google Scholar
• NakashimaHSuzukiHOhtsuH2006Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculatureCurr Vasc Pharmacol4677816472178
   PubMedGoogle Scholar
• NavarLGHarrisonBLImigJD2000Renal responses to AT(1) receptor blockadeAm J Hypertens13S4554
   PubMed Web of Science ®Google Scholar
• NavarLGNishiyamaA2004Why are angiotensin concentrations so high in the kidney?Curr Opin Nephrol Hypertens131071515090867
   PubMed Web of Science ®Google Scholar
• NguyenGDelarueFBurckleC2002Pivotal role of the renin/pro-renin receptor in angiotensin II production and cellular responses to reninJ Clin Invest10914172712045255
   PubMed Web of Science ®Google Scholar
• NielsenAHSchauserKHPoulsenK2000Current topic: the uteropla cental renin-angiotensin systemPlacenta214687710940196
   PubMed Web of Science ®Google Scholar
• NogueiraAISantosRASSimões e SilvaAC2007The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetesRegul Pep1415560
   PubMedGoogle Scholar
• NouetSNahmiasC2000Signal transduction from the Angiotensin II AT2 receptorTrends Endocrinol Metab111610652498
   PubMed Web of Science ®Google Scholar
• OrcaranzaMPGodoyIJalilJE2006Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted ratHypertension48572816908757
   PubMed Web of Science ®Google Scholar
• PadiaSHHowellNLSiragyHM2006Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked ratHypertension475374416380540
   PubMed Web of Science ®Google Scholar
• PadiaSHKempBAHowellNL2007Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked ratsHypertension496253017190872
   PubMed Web of Science ®Google Scholar
• PaizisGTikellisCCooperME2005Chronic liver injury in rat and man upregulates the novel enzyme angiotensin converting enzyme IIGut541790616166274
   PubMed Web of Science ®Google Scholar
• ParvingHHLehnertHBrochner-MortensenJfor the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group2001The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med345870811565519
   PubMed Web of Science ®Google Scholar
• PatelJMMartensJRLiYD1998Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxationAm J Physiol275L106189843842
   PubMedGoogle Scholar
• PaulMMehrAPKreutzR2006Physiology of local renin-angiotensin systemsPhysiol Rev8674780316816138
   PubMed Web of Science ®Google Scholar
• PaulaRDLimaCVKhoslaMC1995Angiotensin -(1–7) potentiates the hypotensive effect of bradykinin in conscious ratsHypertension26115497498987
   PubMed Web of Science ®Google Scholar
• PechánováOSimkoF2007The role of nitric oxide in the maintenance of vasoactive balancePhysiol Res56Suppl 2S71617824812
   PubMedGoogle Scholar
• PereiraRMSantosRASTeixeiraMM2007The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of angiotensin-(1–7)J Hepatol466748117188388
   PubMed Web of Science ®Google Scholar
• PlovsingRRWambergCSandgaardNC2003Effects of truncated angiotensins in humans after double blockade of the renin systemAm J Physiol285R98191
   Google Scholar
• PorstiIBaraATBusseR1994Release of nitric oxide by angiotensin-(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptorBr J Pharmacol11165248019744
   PubMed Web of Science ®Google Scholar
• PriceDADe’OliveiraJMFisherND1999The state and responsiveness of the renin-angiotensin system in patients with type II diabetes mellitusAm J Hypertens123485510232494
   PubMed Web of Science ®Google Scholar
• ReRN2003Intracellular renin and the nature of intracrine enzymesHypertension421172212860832
   PubMed Web of Science ®Google Scholar
• RiceGIThomasDAGrantPJ2004Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolismBiochem J383455115283675
   PubMed Web of Science ®Google Scholar
• RicheyJMAderMMooreD1999Angiotensin II induces insulin resistance independent of changes in interstitial insulinAm J Physiol2779206
   PubMed Web of Science ®Google Scholar
• RodriguezAFortuñoAGómez-AmbrosiJ2007The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smoth muscle cells is mediated via a nitric oxide-dependent mechanismEndocrinology1483243117038553
   PubMed Web of Science ®Google Scholar
• RomeoGRMoultonKSKazlauskasA2007Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouseCirc Res1013283017702977
   PubMed Web of Science ®Google Scholar
• Ruiz-OrtegaMLorenzoOEgidoJ2000Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cellsKidney Int5722859810844599
   PubMed Web of Science ®Google Scholar
• RydénMArnerP2007Tumour necrosis factor-alpha in human adipose tissue – from signaling mechanisms to clinical implicationsJ Intern Med262431817875179
   PubMed Web of Science ®Google Scholar
• SampaioWOHenrique de CastroCSantosRA2007aAngiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cellsHypertension501093817984366
   PubMed Web of Science ®Google Scholar
• SampaioWOSouza dos SantosRAFaria-SilvaR2007bAngiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthese activation via Akt-dependent pathwaysHypertension491859217116756
   PubMed Web of Science ®Google Scholar
• SantosRASBrosnihanKBChappellMC1988Converting enzyme activity and angiotensin metabolism in the dog brainstemHypertension1115373277912
   PubMed Web of Science ®Google Scholar
• SantosRASFerreiraAJ2005Cardiovascular actions of Angiotensin-(1–7)Braz J Med Biol Res3849950715962175
   PubMed Web of Science ®Google Scholar
• SantosRASFerreiraAJ2007Angiotensin-(1–7) and the reninangiotensin systemCurr Opin Nephrol Hypertens16122817293687
   PubMed Web of Science ®Google Scholar
• SantosRASSimões e SilvaACMaricC2003Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor MasProc Natl Acad Sci USA10082586312829792
   PubMed Web of Science ®Google Scholar
• SantosSHFernandesLRMarioEG2008Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolismDiabetes57340718025412
   PubMed Web of Science ®Google Scholar
• SarzaniRMarcucciPSalviP2008Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growthInt J Obes3225967
   Web of Science ®Google Scholar
• SasakiKYamanoYBardhanS1991Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptorNature35123032041569
   PubMed Web of Science ®Google Scholar
• SavoiaCSchiffrinEL2007Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventionsClin Sci1123758417324119
   PubMed Web of Science ®Google Scholar
• SchiavoneMTSantosRASBrosnihanKB1988Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1–7) heptapeptideProc Natl Acad Sci USA85409583375255
   PubMed Web of Science ®Google Scholar
• SchmiederREHilgersKFSchlaichPM2007Renin-angiotensin system and cardiovascular riskLancet36912081917416265
   PubMed Web of Science ®Google Scholar
• SerniaC2001A critical appraisal of the intrinsic pancreatic angiotensin-generating systemJOP250511862023
   PubMedGoogle Scholar
• ShahDM2005Role of the renin-angiotensin system in the pathogenesis of preeclampsiaAm J Physiol Renal Physiol288F6142515753325
   PubMed Web of Science ®Google Scholar
• Simões e SilvaACDinizJSPereiraRM2006bCirculating renin angiotensin system in childhood chronic renal failure: Marked increase of angiotensin-(1–7) in end-stage renal diseasePediatr Res607349
   PubMed Web of Science ®Google Scholar
• Simões e SilvaACDinizJSRegueira-FilhoA2004The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1–7) in essential hypertensionJ Pediatr14593815238914
   PubMed Web of Science ®Google Scholar
• Simões e SilvaACPinheiroSVBPereiraRM2006aThe therapeutic potential of Angiotensin-(1–7) as a novel Renin Angiotensin System mediatorMini Rev Med Chem66039
   PubMed Web of Science ®Google Scholar
• Simões e SilvaAC2006cPathophysiology of arterial hypertension: Insights from pediatric studiesCurr Pediatr Rev220923
   Google Scholar
• SinghRAlaviNSinghAK1999Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradationDiabetes4820667310512375
   PubMed Web of Science ®Google Scholar
• SkeggsLTJrKahnJRShumwayNP1956The preparation and function of the hypertensin-converting enzymeJ Exp Med103295913295487
   PubMed Web of Science ®Google Scholar
• SlinkerBKWuYBrennanAJ1999Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxationCardiovasc Res42660910533606
   PubMed Web of Science ®Google Scholar
• SpätAHunyadyL2004Control of aldosterone secretion: a model for convergence in cellular signaling pathwaysPhysiol Rev8448953915044681
   PubMed Web of Science ®Google Scholar
• SpillertCRSunSMillerMA1994Hypertension-related coronary thrombosis: prothrombic role of angiotensin IIJ Natl Med Assoc8668687966432
   PubMed Web of Science ®Google Scholar
• StaessenJALiYRichartT2006Oral renin inhibitorsLancet36814495617055947
   PubMed Web of Science ®Google Scholar
• SuzukiSDoiYAoiW1984Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjectsJpn Heart J2575856376863
   PubMedGoogle Scholar
• TallantEAFerrarioCMGallagherPE2005Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptorAm J Physiol289H15606
   PubMed Web of Science ®Google Scholar
• TikellisCJohnstonCIForbesJM2003Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathyHypertension41392712623933
   PubMed Web of Science ®Google Scholar
• TipnisSRHooperNMHydeR2000A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidaseJ Biol Chem275332384310924499
   PubMed Web of Science ®Google Scholar
• TouyzRMSchiffrinEL2000Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cellsPharmacol Rev526397211121512
   PubMed Web of Science ®Google Scholar
• VellosoLAFolliFPeregoL2006The multi-faceted crosstalk between the insulin and angiotensin II signaling systemsDiabetes Metab Res Rev229810716389635
   PubMed Web of Science ®Google Scholar
• VickersCHalesPKaushikV2002Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidaseJ Biol Chem277148384311815627
   PubMed Web of Science ®Google Scholar
• VijayaraghavanKDeedwaniaPC2005The renin angiotensin system as a therapeutic target to prevent diabetes and its complicationsCardiol Clin231658315694745
   PubMed Web of Science ®Google Scholar
• VincentMAMontagnaniMQuonMJ2003Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulinAm J Physiol285E12330
   PubMed Web of Science ®Google Scholar
• WarnerFJLubelJSMcCaughanGW2007Liver fibrosis: a balance of ACEs?Clin Sci (Lond)11310818
   Web of Science ®Google Scholar
• WatanabeTBarkerTABerkBC2005Angiotensin II and the endothelium: Diverse signals and effectsHypertension45163915630047
   PubMed Web of Science ®Google Scholar
• WeberKT2001Aldosterone in congestive heart failureN Engl J Med34516899711759649
   PubMed Web of Science ®Google Scholar
• WeirMR2007Effects of renin-angiotensin system inhibition end-organ protection: can we do better?Clin Ther2918032418035185
   PubMed Web of Science ®Google Scholar
• WijpkemaJSvan HaelstPLMonraatsPS2006Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1Pharmacogenet Genomics16331716609364
   PubMed Web of Science ®Google Scholar
• WinkelmannBRRussAPNauckM1999Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular diseaseAm Heart J13769870510097233
   PubMed Web of Science ®Google Scholar
• WolfGZiyadehFN1997The role of angiotensin II in diabetic nephropathy: enphasis on non-hemodynamic mechanismsAm J Kidney Dis29153669002545
   PubMed Web of Science ®Google Scholar
• YangWHuangWSuS2007Association study of angiotensin I converting enzyme 2 gene polymorphisms with coronary heart disease and myocardial infarction in Chinese Han populationClin Sci (Lond)1113334016822235
   PubMed Web of Science ®Google Scholar
• Yki-JarvinenH2003Non-glycemic effects of insulinClin Cornerstone, Suppl4S612
   Google Scholar
• YusufSGersteinHHoogwerfB2001Ramipril and the development of diabetesJAMA28618828511597291
   PubMed Web of Science ®Google Scholar
• ZamanMAOparilSCalhoumDA2002Drugs targeting the renin-angiotensin aldosterone systemNature162136
   Web of Science ®Google Scholar
• ZhongJYanZLiuD2006Association of angiotensin converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chi nese patients with metabolic syndromeJ Lab Clin Med14791516459167
   PubMed Web of Science ®Google Scholar
• ZismanLSKellerRSWeaverB2003Increased angiotensin-(1–7)-forming activity in failing human heart ventricles: evidence for up regulation of the angiotensin-converting enzyme homologue ACE2Circulation10817071214504186
   PubMed Web of Science ®Google Scholar